These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18545238)

  • 1. Delayed lymphocyte infusion in children given SCT.
    Klingebiel T; Bader P;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S23-6. PubMed ID: 18545238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia.
    Hoelle W; Beck JF; Dueckers G; Kreyenberg H; Lang P; Gruhn B; Führer M; Niethammer D; Klingebiel T; Bader P
    Bone Marrow Transplant; 2004 Jan; 33(2):219-23. PubMed ID: 14647253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population.
    Levine JE; Barrett AJ; Zhang MJ; Arora M; Pulsipher MA; Bunin N; Fort J; Loberiza F; Porter D; Giralt S; Drobyski W; Wang D; Pavletic S; Ringden O; Horowitz MM; Collins R
    Bone Marrow Transplant; 2008 Aug; 42(3):201-5. PubMed ID: 18490913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia.
    Formánková R; Honzátková L; Sieglová Z; Starý J; Sedlácek P; Brdicka R
    Bone Marrow Transplant; 2000 Feb; 25(4):453-6. PubMed ID: 10723591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
    Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
    Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imminent allograft rejection prevented by donor lymphocyte transfusions: report of two pediatric cases.
    Saarinen-Pihkala UM; Taskinen M; Vettenranta K; Hovi L
    Bone Marrow Transplant; 2003 May; 31(9):833-6. PubMed ID: 12732894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy.
    Bader P; Niemeyer C; Willasch A; Kreyenberg H; Strahm B; Kremens B; Gruhn B; Dilloo D; Vormoor J; Lang P; Niethammer D; Klingebiel T; Beck JF
    Br J Haematol; 2005 Mar; 128(5):649-58. PubMed ID: 15725087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of JMML relapsed after unrelated allogeneic transplant with cytoreduction followed by DLI and interferon-alpha: evidence for a graft-versus-leukemia effect in non-monosomy-7 JMML.
    Pulsipher MA; Adams RH; Asch J; Petersen FB
    Bone Marrow Transplant; 2004 Jan; 33(1):113-5. PubMed ID: 14704663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of late graft-versus-host disease in a patient post-allogeneic stem cell transplantation by progesterone in conjunction with donor lymphocyte infusion.
    Gesundheit B; Shapira MY; Maly A; Samuel S; Budowski E; Or R
    Leuk Res; 2008 Mar; 32(3):501-3. PubMed ID: 17727947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of late CML relapse.
    Flowers M
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):847-8. PubMed ID: 18541206
    [No Abstract]   [Full Text] [Related]  

  • 12. Chimerism-directed adoptive immunotherapy in prevention and treatment of post-transplant relapse of leukemia in childhood.
    Formánková R; Sedlácek P; Krsková L; Ríhová H; Srámková L; Star J;
    Haematologica; 2003 Jan; 88(1):117-8. PubMed ID: 12551838
    [No Abstract]   [Full Text] [Related]  

  • 13. Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders.
    Ozyurek E; Cowan MJ; Koerper MA; Baxter-Lowe LA; Dvorak CC; Horn BN
    Bone Marrow Transplant; 2008 Jul; 42(2):83-91. PubMed ID: 18391990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of post-transplant remission of childhood malignancies: is there a standard?
    Bader P; Willasch A; Klingebiel T
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S31-4. PubMed ID: 18978741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor lymphocyte infusions: the long and winding road: how should it be traveled?
    Tomblyn M; Lazarus HM
    Bone Marrow Transplant; 2008 Nov; 42(9):569-79. PubMed ID: 18711351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.
    Maurillo L; Buccisano F; Del Principe MI; Del Poeta G; Spagnoli A; Panetta P; Ammatuna E; Neri B; Ottaviani L; Sarlo C; Venditti D; Quaresima M; Cerretti R; Rizzo M; de Fabritiis P; Lo Coco F; Arcese W; Amadori S; Venditti A
    J Clin Oncol; 2008 Oct; 26(30):4944-51. PubMed ID: 18606980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
    Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease.
    Kim SY; Lee DG; Kim MS; Kim HJ; Lee S; Min CK
    Am J Hematol; 2008 Oct; 83(10):784-8. PubMed ID: 18661492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia.
    Frugnoli I; Cappelli B; Chiesa R; Biral E; Noè A; Evangelio C; Fossati M; Napolitano S; Ciceri F; Roncarolo MG; Marktel S
    Bone Marrow Transplant; 2010 Jun; 45(6):1047-51. PubMed ID: 19881553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse.
    Pulsipher MA; Bader P; Klingebiel T; Cooper LJ
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):62-71. PubMed ID: 19147081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.